Supplementary Table S1. Toxicities. from Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)

Authors :: Michael J. Weber
Jeffrey E. Gershenwald
Prahlad Ram
Gulsun Erdag
Sofia M. Shea
Lainie Martin
Anthony J. Olszanski
Aubrey G. Wagenseller
Geoffrey R. Weiss
William W. Grosh
Cheryl Murphy Chase
Alison Gaucher
Walter C. Olson
Mark E. Smolkin
Amber L. Shada
Kimberly A. Chianese-Bullock
David L. Brautigan
Kerrington R. Molhoek
Gina R. Petroni
Craig L. Slingluff
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Detail of treatment-related toxicities.

Tools